• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型组织学评分系统作为肌肉浸润性膀胱癌潜在分级方法的研究提案,与疾病侵袭性和患者预后相关。

Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes.

机构信息

Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.

Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany; Department of Nephropathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

出版信息

Eur Urol Oncol. 2024 Feb;7(1):128-138. doi: 10.1016/j.euo.2023.07.011. Epub 2023 Aug 8.

DOI:10.1016/j.euo.2023.07.011
PMID:37562993
Abstract

BACKGROUND

Grading of muscle-invasive bladder cancer (MIBC) according to the current World Health Organization (WHO) criteria is controversial due to its limited prognostic value. All MIBC cases except a tiny minority are of high grade.

OBJECTIVE

To develop a prognostic histological scoring system for MIBC integrating histomorphological phenotype, stromal tumor-infiltrating lymphocytes (sTILs), tumor budding, and growth and spreading patterns.

DESIGN, SETTING, AND PARTICIPANTS: Tissue specimens and clinical data of 484 patients receiving cystectomy and lymphadenectomy with curative intent with or without adjuvant chemotherapy. Histomorphological phenotypes, sTILs, tumor budding, and growth and spreading patterns were evaluated and categorized into four grade groups (GGs). GGs were correlated with molecular subtypes, immune infiltration, immune checkpoint expression, extracellular matrix (ECM) remodeling, and epithelial-mesenchymal transition (EMT) activity.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

GGs were associated with overall (OS), disease-specific (DSS), and progression-free (PFS) survival in univariable and multivariable analyses. Association with biological features was analyzed with descriptive statistics.

RESULTS AND LIMITATIONS

Integration of two histomorphological tumor groups, three sTILs groups, three tumor budding groups, and four growth/spread patterns yielded four novel GGs that had high significance in the univariable survival analysis (OS, DSS, and PFS). GGs were confirmed as independent prognostic predictors with the greatest effect in the multivariable Cox regression analysis. Correlation with molecular data showed a gradual transition from basal to luminal subtypes from GG1 to GG4; a gradual decrease in survival, immune infiltration, and immune checkpoint activity; and a gradual increase in ECM remodeling and EMT activity.

CONCLUSIONS

We propose a novel, prognostically relevant, and biologically based scoring system for MIBC in cystectomies applicable to routine pathological sections.

PATIENT SUMMARY

We developed a novel approach to assess the aggressiveness of advanced bladder cancer, which allows improved risk stratification compared with the method currently proposed by the World Health Organization.

摘要

背景

根据目前的世界卫生组织(WHO)标准对肌层浸润性膀胱癌(MIBC)进行分级存在争议,因为其预后价值有限。除极少数情况外,所有 MIBC 病例均为高级别。

目的

建立一种新的 MIBC 预后组织学评分系统,该系统整合了组织形态学表型、间质肿瘤浸润淋巴细胞(sTILs)、肿瘤芽生和生长及扩散模式。

设计、地点和参与者:对 484 例接受根治性膀胱切除术和淋巴结切除术且接受或未接受辅助化疗的患者的组织标本和临床数据进行评估。评估并将组织形态学表型、sTILs、肿瘤芽生和生长及扩散模式分为四个等级组(GG)。GG 与分子亚型、免疫浸润、免疫检查点表达、细胞外基质(ECM)重塑和上皮-间充质转化(EMT)活性相关。

结局测量和统计分析

在单变量和多变量分析中,GG 与总生存(OS)、疾病特异性生存(DSS)和无进展生存(PFS)相关。使用描述性统计方法分析与生物学特征的相关性。

结果和局限性

整合两种组织形态学肿瘤组、三种 sTIL 组、三种肿瘤芽生组和四种生长/扩散模式,产生了四个新的 GG,在单变量生存分析(OS、DSS 和 PFS)中具有高显著性。GG 在多变量 Cox 回归分析中被确认为独立的预后预测因子,其影响最大。与分子数据的相关性表明,从 GG1 到 GG4,从基底型向 luminal 型逐渐过渡;生存、免疫浸润和免疫检查点活性逐渐降低;ECM 重塑和 EMT 活性逐渐增加。

结论

我们提出了一种新的、具有预后相关性且基于生物学的 MIBC 评分系统,适用于膀胱切除术的常规病理切片。

患者总结

我们开发了一种评估晚期膀胱癌侵袭性的新方法,与目前世界卫生组织提出的方法相比,可进行更好的风险分层。

相似文献

1
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes.新型组织学评分系统作为肌肉浸润性膀胱癌潜在分级方法的研究提案,与疾病侵袭性和患者预后相关。
Eur Urol Oncol. 2024 Feb;7(1):128-138. doi: 10.1016/j.euo.2023.07.011. Epub 2023 Aug 8.
2
A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer.一种新的分级方法预测 pT1 期非肌肉浸润性膀胱癌的结局更差。
BJU Int. 2024 Aug;134(2):249-257. doi: 10.1111/bju.16298. Epub 2024 Feb 26.
3
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy.在根治性膀胱切除术治疗肌层浸润性膀胱癌患者中的基质肿瘤浸润淋巴细胞评分(sTILs)对风险分层的作用。
Urol Oncol. 2022 Feb;40(2):63.e19-63.e26. doi: 10.1016/j.urolonc.2021.07.025. Epub 2021 Aug 20.
4
Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.高危非肌肉浸润性膀胱癌(HGT1)中,分子亚型比上皮-间质转化(EMT)标志物具有更好的预后预测价值。
J Pathol Clin Res. 2020 Oct;6(4):238-251. doi: 10.1002/cjp2.167. Epub 2020 May 6.
5
Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer.免疫和基质浸润对肌层浸润性膀胱癌保膀胱三联疗法后结局的影响。
Eur Urol. 2019 Jul;76(1):59-68. doi: 10.1016/j.eururo.2019.01.011. Epub 2019 Feb 1.
6
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy.细胞毒性T细胞相关基因表达特征预测肌肉浸润性尿路上皮膀胱癌患者根治性膀胱切除术后及辅助化疗后的生存改善。
J Immunother Cancer. 2020 May;8(1). doi: 10.1136/jitc-2019-000162.
7
Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of , , and in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy.在接受辅助化疗的肌肉浸润性膀胱癌中,通过 RT-qPCR 确定 、 、 和分子亚型后,在蛋白质和 mRNA 水平上定量存活素和巨噬细胞浸润的预后作用。
Int J Mol Sci. 2020 Oct 8;21(19):7420. doi: 10.3390/ijms21197420.
8
Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?三标志物免疫组化评估肌层浸润性膀胱癌:是否有预后意义?
Cancer Rep (Hoboken). 2021 Apr;4(2):e1313. doi: 10.1002/cnr2.1313. Epub 2021 Feb 4.
9
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.原发性和继发性肌层浸润性膀胱癌之间的基因组差异是基于顺铂为基础的新辅助化疗疗效差异的基础。
Eur Urol. 2019 Feb;75(2):231-239. doi: 10.1016/j.eururo.2018.09.002. Epub 2018 Oct 2.
10
Bladder Tumor Subtype Commitment Occurs in Carcinoma Driven by Key Signaling Pathways Including ECM Remodeling.膀胱癌亚型的形成与关键信号通路有关,包括细胞外基质重塑,这些通路驱动了癌的发生。
Cancer Res. 2021 Mar 15;81(6):1552-1566. doi: 10.1158/0008-5472.CAN-20-2336. Epub 2021 Jan 20.

引用本文的文献

1
Role of the tumor microenvironment in promoting treatment resistance in urothelial carcinoma (Review).肿瘤微环境在促进尿路上皮癌治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13658. Epub 2025 Aug 24.
2
The ETS transcription factor GABPA inhibits bladder cancer aggressiveness by repressing extracellular matrix deposition and mechanotransduction signaling.ETS转录因子GABPA通过抑制细胞外基质沉积和机械转导信号来抑制膀胱癌的侵袭性。
Cell Death Dis. 2025 Aug 14;16(1):618. doi: 10.1038/s41419-025-07935-z.
3
Deep learning-based lymph node metastasis status predicts prognosis from muscle-invasive bladder cancer histopathology.
基于深度学习的淋巴结转移状态可从肌层浸润性膀胱癌组织病理学预测预后。
World J Urol. 2025 Jan 10;43(1):65. doi: 10.1007/s00345-025-05440-8.
4
Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN.多尺度金字塔卷积神经网络精准分级非肌层浸润性膀胱癌。
Sci Rep. 2024 Oct 24;14(1):25131. doi: 10.1038/s41598-024-77101-6.
5
[Muscle-invasive and metastatic urothelial carcinoma of the urinary bladder : Current state of histopathologic, molecular, and immunologic prognostic and predictive factors].[膀胱肌层浸润性和转移性尿路上皮癌:组织病理学、分子和免疫预后及预测因素的现状]
Pathologie (Heidelb). 2024 Nov;45(6):363-370. doi: 10.1007/s00292-024-01347-0. Epub 2024 Aug 7.
6
Predictors of Local Invasion in Infiltrative Basal Cell Carcinoma: Tumour Budding Outperforms the WHO Subtyping.浸润性基底细胞癌局部侵袭的预测因子:肿瘤芽出优于 WHO 分型。
Acta Derm Venereol. 2024 Jul 2;104:adv40172. doi: 10.2340/actadv.v104.40172.
7
Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic Review.数字病理学中用于膀胱癌的人工智能:炒作还是希望?一项系统综述。
Cancers (Basel). 2023 Sep 12;15(18):4518. doi: 10.3390/cancers15184518.